Literature DB >> 35907169

Evaluation of a Functional Craft Wheat Beer Fermented with Saccharomyces cerevisiae UFMG A-905 to treat Salmonella Typhimurium infection in mice.

Samantha R M Oliveira1,2, Lara L Campos1, Maisa N S Amaral1, Bruno Galotti1, Mayra F Ricci3, Katia D Vital4, Ramon O Souza1, Ana Paula T Uetanabaro2, Mateus S Junqueira5, Andreia M Silva5, Simone O A Fernandes4, Valbert N Cardoso4, Jacques R Nicoli6, Flaviano S Martins1.   

Abstract

Functional foods containing probiotics are generally administered as dairy products. Non-dairy beverages are another possibility, but probiotic functionality must be confirmed in such vehicles. In the present study, a craft wheat beer brewed with the probiotic yeast Saccharomyces cerevisiae UFMG A-905 (905) was evaluated in a murine model of Salmonella Typhimurium infection. Unfiltered or filtered beer brewed with 905, a commercial wheat beer used as a negative control, or saline were administered orally to mice before and during oral S. Typhimurium challenge. High fecal levels of yeast were only counted in mice treated with the unfiltered 905 beer, which also had reduced mortality and body weight loss due to S. Typhimurium infection. Increased levels of intestinal IgA, translocation to liver and spleen, liver and intestinal lesions, pro-inflammatory cytokines in liver and ileum, and hepatic and intestinal myeloperoxidase and eosinophilic peroxidase activities were observed in animals infected with S. Typhimurium. All these parameters were reduced by the treatment with unfiltered 905 beer. In conclusion, the results show that a craft wheat beer brewed with S. cerevisiae UFMG A-905 maintained the probiotic properties of this yeast when administered orally to mice challenged with S. Typhimurium.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Functional foods; Probiotic; Saccharomyces cerevisiae; Salmonella Typhimurium; Wheat beer

Year:  2022        PMID: 35907169     DOI: 10.1007/s12602-022-09973-x

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   5.265


  19 in total

1.  Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model.

Authors:  Simone V Generoso; Mirelle Viana; Rosana Santos; Flaviano S Martins; José A N Machado; Rosa M E Arantes; Jacques R Nicoli; Maria I T D Correia; Valbert N Cardoso
Journal:  Arch Microbiol       Date:  2010-05-01       Impact factor: 2.552

Review 2.  Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics.

Authors:  Mary Ellen Sanders; Todd R Klaenhammer; Arthur C Ouwehand; Bruno Pot; Eric Johansen; James T Heimbach; Maria L Marco; Julia Tennilä; R Paul Ross; Charles Franz; Nicolas Pagé; R David Pridmore; Greg Leyer; Seppo Salminen; Duane Charbonneau; Emma Call; Irene Lenoir-Wijnkoop
Journal:  Ann N Y Acad Sci       Date:  2014-02       Impact factor: 5.691

3.  Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever.

Authors:  Flaviano S Martins; Samir D A Elian; Angélica T Vieira; Fabiana C P Tiago; Ariane K S Martins; Flávia C P Silva; Ericka L S Souza; Lirlândia P Sousa; Helena R C Araújo; Paulo F Pimenta; Cláudio A Bonjardim; Rosa M E Arantes; Mauro M Teixeira; Jacques R Nicoli
Journal:  Int J Med Microbiol       Date:  2011-01-13       Impact factor: 3.473

4.  Oral administration of Saccharomyces cerevisiae UFMG A-905 prevents allergic asthma in mice.

Authors:  Vanessa M B Fonseca; Thamires M S Milani; Rafael Prado; Vania L D Bonato; Simone G Ramos; Flaviano S Martins; Elcio O Vianna; Marcos de C Borges
Journal:  Respirology       Date:  2017-02-06       Impact factor: 6.424

5.  Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice.

Authors:  Flariano S Martins; Regina M D Nardi; Rosa M E Arantes; Carlos A Rosa; Maria J Neves; Jacques R Nicoli
Journal:  J Gen Appl Microbiol       Date:  2005-04       Impact factor: 1.452

6.  Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice.

Authors:  Flaviano S Martins; Ana Cristina P Rodrigues; Fabiana C P Tiago; Francisco J Penna; Carlos A Rosa; Rosa M E Arantes; Regina M D Nardi; Maria J Neves; Jacques R Nicoli
Journal:  J Med Microbiol       Date:  2007-03       Impact factor: 2.472

7.  A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae.

Authors:  Jinshui Zheng; Stijn Wittouck; Elisa Salvetti; Charles M A P Franz; Hugh M B Harris; Paola Mattarelli; Paul W O'Toole; Bruno Pot; Peter Vandamme; Jens Walter; Koichi Watanabe; Sander Wuyts; Giovanna E Felis; Michael G Gänzle; Sarah Lebeer
Journal:  Int J Syst Evol Microbiol       Date:  2020-04-15       Impact factor: 2.747

8.  Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics.

Authors:  F C P Tiago; F S Martins; E L S Souza; P F P Pimenta; H R C Araujo; I M Castro; R L Brandão; Jacques R Nicoli
Journal:  J Med Microbiol       Date:  2012-05-11       Impact factor: 2.472

9.  Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.

Authors:  Angela Capece; Rossana Romaniello; Angela Pietrafesa; Gabriella Siesto; Rocchina Pietrafesa; Marianna Zambuto; Patrizia Romano
Journal:  Int J Food Microbiol       Date:  2018-07-02       Impact factor: 5.277

Review 10.  Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.

Authors:  M A Lazo-Vélez; S O Serna-Saldívar; M F Rosales-Medina; M Tinoco-Alvear; M Briones-García
Journal:  J Appl Microbiol       Date:  2018-08-16       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.